Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based drug design

L M Amzel1

  • 1Department of Biophysics and Biophysical Chemistry, Johns Hopkins School of Medicine, Baltimore, Md. 21205, USA. mario@neruda.med.jhmi.edu

Current Opinion in Biotechnology
|August 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with pyrazinoic acid.

Scientific reports·2020
Same author

Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.

Oncogene·2017
Same author

Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations.

Journal of virology·2007
Same author

Structures and mechanisms of Nudix hydrolases.

Archives of biochemistry and biophysics·2004
Same author

Notes on the mechanism of ATP synthesis.

Journal of bioenergetics and biomembranes·2004
Same author

Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches.

Biochemistry·2001
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Structure-based drug design techniques have advanced significantly, improving speed and efficacy. Future drug development will integrate these structure-based methods with other strategies for optimal results.

Area of Science:

  • Biochemistry and Medicinal Chemistry
  • Computational Drug Discovery

Background:

  • Structure-based drug design (SBDD) has seen rapid advancements.
  • Combinatorial chemistry was previously considered the primary future strategy.

Purpose of the Study:

  • To highlight the recent improvements in SBDD techniques.
  • To discuss the evolving landscape of drug design methodologies.

Main Methods:

  • Review of recent advancements in SBDD techniques.
  • Analysis of the role of SBDD in modern drug discovery.

Main Results:

  • Significant enhancements in the speed and efficacy of SBDD.
  • Growing evidence supporting the integration of SBDD in future drug development.

Related Experiment Videos

Conclusions:

  • SBDD is a crucial component of future drug design.
  • A hybrid approach combining SBDD with other methods will be most effective.